International Clinical Trials Workshop - ICTW

The ASCO International Clinical Trials Workshop (ASCO ICTW) supports cancer research in economically emerg-ing countries through the development of research skills of clinicians in those countries. The purpose of the ASCO ICTW is to educate members of the research team on best practices of clinical trial implementation. The two-day workshops are held in emerging economy countries and organized in collaboration with a nation-al or regional oncology society.

Opatija, Milenij Grand Hotel 4 opatijska cvijeta
10.-12.6.2013.

PROGRAMME:

DAY 1 (June 12, 2013) 08:00 Registration 09:00 Welcome and Introductions (T Cufer, E Vrdoljak) 09:50 Partners in clinical research I
1. Academic perspective (G Fisher)
2. Industry Perspective (S Bolanca)
3. Government perspective (S Primozic) 10:50 Coffee break 11:15 Partners in clinical research: Panel Discussion (A Eniu, T Cufer, G Fisher ,S Bolanca, S Primozic, , B Seruga, B Sikic, I Tannock, E Vrdoljak) 12.00 Reading the literature with a critical eye: recognizing and learning from the mistakes of others (I Tannock) 12.30 Lunch 14:00 Clinical trials planning and conducting (1)
1. Design and methodology phase I trials (B Sikic)
2. Design and methodology of Phase II trials (G Fisher)
3. Design and methodology-phase III (IV) trials (I Tannock) 15.30 Coffee break 15:45 Clinical trials planning and conducting (2)
4. Statistical considerations (B Hasan)
5. Ethical considerations (E Vrdoljak)
6. Protocol document- a reflection of the trial design (B Sikic)
17:15 End of Day 1

DAY 2 (June 13, 2013) 09:00 Clinical trials planning and conducting (3)
7. How to build a successful Oncology Research team (A Eniu)
8. Data handling (B Hasan)
9. Regulatory issues (E Vrdoljak) 10:30 Coffee break 10:30 Workshops – discussing protocols of phase II and phase III clinical trials (T Cufer, A Eniu, A Filipovic, G Fisher, B Hasan, S Sadikov, B Seruga, B Sikic, I Tannock, E Vrdoljak) 13.00 Working Lunch 14.00 Publishing the results of your trial (I Tannock) 14.30 Promotion and transparency of clinical research (T Cufer) 15.00 Challenges and opportunities to cancer research: a young oncologist’s perspective (A Filipovic) 15:30 Closing remarks with summary of the working groups (all) 16:00 Adjourn